DRREDDY \u2014 Recent Activity

ESPR's Q4 Earnings Lag Estimates, Revenues Beat, Stock Down

Esperion Therapeutics' Q4 revenues surge 144% to $168.4M but EPS of 22 cents misses estimates. Shares fall as mixed results weigh on sentiment.

Click to open →

Zacks Industry Outlook Highlights Teva Pharmaceuticals, Sandoz and Dr. Reddy's

TEVA, Sandoz and Dr. Reddy's are shifting toward complex generics and biosimilars to counter pricing pressure and strengthen margins in the competitive generics market.

Click to open →

3 Generic Drug Stocks to Watch Despite Industry Headwinds

Generic drugmakers face pricing pressure, but companies like TEVA, SDZNY and RDY are betting on complex generics and biosimilars to protect growth.

Click to open →

Asian Equities Traded in the US as American Depositary Receipts Decline in Tuesday Trading

Asian equities traded in the US as American depositary receipts were trending lower Tuesday morning,

Click to open →

Coya Therapeutics to sell 2.522M shares at $4.40 in private placement

Coya Therapeutics (COYA) announced that it has entered into a definitive securities purchase agreement for the purchase and sale of an aggregate of 2.522M shares of its common stock in a private placement at a price of $4.40 per share. The offering is expected to close on or about January 30, subject to the satisfaction of customary closing conditions. The investors in the offering are Dr. Reddy’s (RDY), $10M, and Greenlight Capital, an existing institutional stockholder of the company. The gros

Click to open →

India's Gland Pharma posts higher quarterly profit on strong US, Europe demand

Jan 28 () - India's Gland Pharma reported a nearly 28% jump in third-quarter profit on Wednesday, boosted by strong ​sales in the key European and U. The Hyderabad-based company ‌reported a consolidated net profit of 2.

Click to open →

Dr Reddy's Laboratories Ltd (RDY) Q3 2026 Earnings Call Highlights: Navigating Growth Amidst ...

Dr Reddy's Laboratories Ltd (RDY) reports steady revenue growth driven by emerging markets and strategic collaborations, despite facing pricing pressures and regulatory hurdles.

Click to open →

Dr. Reddy's Q3 Earnings Match Estimates, Revenues Rise Y/Y

RDY posts flat Q3 earnings, while revenues miss estimates as global generics growth lagged, pressured by weaker North America sales.

Click to open →

Sector Update: Health Care Stocks Higher Late Afternoon

Health care stocks rose late Wednesday afternoon, with the NYSE Health Care Index up 1.5% and the St

Click to open →

Sector Update: Health Care Stocks Rise in Afternoon Trading

Health care stocks rose Wednesday afternoon, with the NYSE Health Care Index up 1% and the State Str

Click to open →